| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/17/1999 | WO1999000148A3 Method for treatment of spinal cord injuries in a mammal |
| 06/17/1999 | CA2315216A1 Tgc method for inducting targeted somatic transgenesis |
| 06/17/1999 | CA2314006A1 Method and composition to enhance the efficacy of a vaccine using chemokines |
| 06/17/1999 | CA2313705A1 Restin and methods of use thereof |
| 06/17/1999 | CA2313607A1 Antagonists of neuropilin receptor function and use thereof |
| 06/17/1999 | CA2313390A1 Peptide antagonists of vascular endothelial growth factor |
| 06/17/1999 | CA2313348A1 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 06/17/1999 | CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | CA2312941A1 Peptide-based gemini compounds |
| 06/17/1999 | CA2312890A1 Transfection particles |
| 06/17/1999 | CA2312698A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 06/17/1999 | CA2312697A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 06/17/1999 | CA2312484A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
| 06/17/1999 | CA2312291A1 Novel vectors and genes exhibiting increased expression |
| 06/17/1999 | CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | CA2312006A1 Nucleic acid mediated rna tagging and rna revision |
| 06/16/1999 | EP0922768A2 Oncogene or virus-driven expression systems |
| 06/16/1999 | EP0922762A1 Drug binding protein |
| 06/16/1999 | EP0922114A2 Catalytic nucleic acid and its medical use |
| 06/16/1999 | EP0922110A2 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 06/16/1999 | EP0922105A2 Infectious papillomavirus pseudoviral particles |
| 06/16/1999 | EP0922102A1 Hepatocyte growth factor receptor agonists and uses thereof |
| 06/16/1999 | EP0922100A2 Secreted proteins and polynucleotides encoding them |
| 06/16/1999 | EP0922099A1 Fas ligand-like protein, its production and use |
| 06/16/1999 | EP0922056A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 06/16/1999 | EP0922053A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR |
| 06/16/1999 | EP0921822A1 Animal model for transplantation |
| 06/16/1999 | EP0921821A1 2-methoxyestradiol-induced apoptosis in cancer cells |
| 06/16/1999 | EP0921820A1 Gene therapy for obesity |
| 06/16/1999 | EP0921818A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 06/16/1999 | EP0921816A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen |
| 06/16/1999 | EP0921805A1 Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor |
| 06/16/1999 | EP0669976B1 Screening method using transcription factor DP-1 |
| 06/15/1999 | US5912411 Mice transgenic for a tetracycline-inducible transcriptional activator |
| 06/15/1999 | US5912335 A polynucleotide sequence that codes human 7-transmembrane receptor protein; treatment of infections, hiv, eating disorders, cancers, heart diseases, mental illnesses, huntington's disease, tourett's and parkinson's disease |
| 06/15/1999 | US5912326 A recombinant polypeptide that is a receptor ligand for the oncogene, erbb; treatment of central nervous diseases, cardiac arrythmias, and amyotrophic lateral sclerosis |
| 06/15/1999 | US5912300 Stabilizing anionic oligonucleotide by complexing(ionic bonding) it with a cationic lysine-serine copolymer, for delivering drugs or genetically active materials to cell interiors where they release smoothly |
| 06/15/1999 | US5912236 Broad-spectrum tumor suppressor genes gene products and methods for tumor suppressor gene therapy |
| 06/15/1999 | US5912173 Vector containing mutated interleukin-2r gamma nucleic acid when transfected into rodents, homologous recombination with x-chromosomes resulting in defective cells; animal models for severe combined immunodeficiency diseases |
| 06/15/1999 | US5912170 Redirection of cellular immunity by protein-tyrosine kinase chimeras |
| 06/15/1999 | US5912168 CD95 regulatory gene sequences |
| 06/15/1999 | US5912159 An isolated human polypeptide which controls nitric oxide biosynthesis; diagnosis and therapy for urea cycle diseases, hypertension, hypotension, prostate cancer/ hyperplasia/ hypertrophy and kidney diseases |
| 06/15/1999 | US5912149 A ribozyme molecule which functions in cis and trans, with a catalytic domain, an antisense domain and target recognition sequence containing self-cleavage site; gene therapy for hiv, hepatitis b virus and t cell leukemia viruses |
| 06/15/1999 | US5912143 Polynucleotides encoding a human mage protein homolog |
| 06/15/1999 | US5912130 Human Homolog of the rat G protein gamma-5 subunit |
| 06/15/1999 | US5912123 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology |
| 06/15/1999 | US5912005 Methods of use of uncoated gel particles |
| 06/15/1999 | US5911989 Antibodies |
| 06/15/1999 | US5911983 Transduction of hematopoietic stem cells |
| 06/10/1999 | WO1999028750A1 Frnk proteins in the treatment of tumor cells |
| 06/10/1999 | WO1999028749A1 USES OF p27 IN PROSTATE CANCER |
| 06/10/1999 | WO1999028489A2 Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer |
| 06/10/1999 | WO1999028488A2 Pseudo-type retroviral vectors with modifiable surface capsid proteins |
| 06/10/1999 | WO1999028486A1 Methods of isolating and using cd7+cd34-lin-hematopoietic cells |
| 06/10/1999 | WO1999028469A1 Compositions and methods for inducing gene expression |
| 06/10/1999 | WO1999028466A1 Compositions and methods of use of het |
| 06/10/1999 | WO1999028459A1 Examination method, examination reagent and remedy for diseases caused by variation in lkb1 gene |
| 06/10/1999 | WO1999028456A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening |
| 06/10/1999 | WO1999028447A1 Human rnase h and compositions and uses thereof |
| 06/10/1999 | WO1999028444A1 Differentiation of adipose stromal cells into osteoblasts and uses thereof |
| 06/10/1999 | WO1999028440A1 Nucleic acid encoding mammalian ubr1 |
| 06/10/1999 | WO1999028439A2 Erythrovirus and its applications |
| 06/10/1999 | WO1999028341A2 Maintenance of smooth muscle integrity by morphogenic proteins |
| 06/10/1999 | WO1999027958A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 06/10/1999 | WO1999027957A1 Vaccination and methods against multiple sclerosis using specific tcr vbeta peptides |
| 06/10/1999 | WO1999027955A2 Treatment of established chronic infections and cancers |
| 06/10/1999 | WO1999015684A3 Expression of genes in hematopoietic stem cells in hischaemic conditions |
| 06/10/1999 | WO1999013073A3 Viral vector system capable of expressing an apoptosis-associated gene |
| 06/10/1999 | WO1999013067A3 Hypoxia inducible promoter |
| 06/10/1999 | WO1999007737A3 Lsr receptor, cloning and uses |
| 06/10/1999 | WO1999006545A8 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
| 06/10/1999 | DE19754103A1 New packaging cell line for E1-deleted adenovirus |
| 06/10/1999 | CA2314423A1 Maintenance of smooth muscle integrity by morphogenic proteins |
| 06/10/1999 | CA2313243A1 Nucleic acid encoding mammalian ubr1 |
| 06/10/1999 | CA2312847A1 Differentiation of adipose stromal cells into osteoblasts and uses thereof |
| 06/10/1999 | CA2312002A1 Human rnase h and compositions and uses thereof |
| 06/10/1999 | CA2311647A1 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 06/10/1999 | CA2311414A1 Diagnostic method, diagnostic reagent and therapeutic preparation for diseases caused by variation in lkb1 gene |
| 06/10/1999 | CA2310541A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening |
| 06/09/1999 | EP0921197A2 Human disintegrin metalloprotease related to drosophila kuz gene |
| 06/09/1999 | EP0921194A2 TRAILLK-2: a member of the TNF ligand family |
| 06/09/1999 | EP0921193A1 Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy |
| 06/09/1999 | EP0920843A1 Drug delivery system |
| 06/09/1999 | EP0920534A1 MUTATIONS IN THE DIABETES SUSCEPTIBILITY GENES HEPATOCYTE NUCLEAR FACTOR (HNF) 1 ALPHA ($g(a)), HNF-1$g(b) AND HNF-4$g(a) |
| 06/09/1999 | EP0920524A1 A short-shafted adenoviral fiber and its use |
| 06/09/1999 | EP0920523A1 Hsv strain lacking functional icp27 and icp34.5 genes |
| 06/09/1999 | EP0920518A1 Stimulus-inducible i (kappa)b kinase ikk] signalsome |
| 06/09/1999 | EP0920515A1 A NOVEL HUMAN mRNA EDITING ENZYME |
| 06/09/1999 | EP0920514A1 Targeting adenovirus with use of constrained peptide motifs |
| 06/09/1999 | EP0920512A1 Dna molecule fragments encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 06/09/1999 | EP0920507A2 Secreted proteins and polynucleotides encoding them |
| 06/09/1999 | EP0920506A1 Human dbi/acbp-like protein |
| 06/09/1999 | EP0920505A1 Mammalian cell surface antigens; related reagents |
| 06/09/1999 | EP0920500A1 Human proteolipid |
| 06/09/1999 | EP0920339A2 Gene delivery system |
| 06/09/1999 | EP0920305A1 Identification of genes altered in multiple myeloma |
| 06/08/1999 | US5910581 Polypeptides of glycosaminoglycan sulfotransferase originating from human and DNA coding for the polypeptides |
| 06/08/1999 | US5910488 Plasmids suitable for gene therapy |
| 06/08/1999 | US5910487 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules |
| 06/08/1999 | US5910486 Introducing into a malignant mammalian cell a nucleic acid molecule encoding an antibody homologue intracellularly which binds to an oncoprotein on cell surface to kill the cell |